secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2022-05-13T23:59:59+00:00
Accession:  0000950170-22-009882
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chairman Jean-Pierre Sommadossi resigns; Graham Cooper appointed Chairman of Kezar Life Sciences
--------------------------------------------------------------------------------

- Jean-Pierre Sommadossi resigned as Chairman and from the Board, effective May 11, 2022, no disagreement with management.
- Board appointed current director Graham Cooper as Chairman on May 12, 2022.
- Cooper received a one-time option to purchase 26,000 shares, vesting monthly over three years contingent on board service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017022009882/0000950170-22-009882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017022009882/kzr-20220511.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-009882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer